CAPRELSA (vandetanib) tablets 300mg

NINLARO (Ixazomib) Capsules
February 12, 2021

CAPRELSA (vandetanib) tablets 300mg


Facts of CAPRELSA (vandetanib) tablets 300mg ?

  • Medicine Name: CAPRELSA
  • Generic Name: Vandetanib
  • Approval Date: Feb 21, 2012
  • Company Name: AstraZeneca Pharmaceuticals LP
  • Available as (Form & Strength): 100 mg and 300mg tablets

What are the indications and usage?

  • CAPRELSA is a kinase inhibitor indicated for the treatment of symptomatic or progressive medullary thyroid cancer in patients with unresectable locally advanced or metastatic disease.
  • Use CAPRELSA in patients with indolent, asymptomatic or slowly progressing disease only after careful consideration of the treatment related risks of CAPRELSA.

Leave a Reply

Your email address will not be published. Required fields are marked *